Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-21

FDA Approved: AJOVY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AJOVY (fremanezumab-vfrm) from Teva Pharmaceuticals USA, Inc., resulting in an approved update to its labeling r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ajovy (fremanezumab)

Snippet

SUPPL AP for AJOVY (FREMANEZUMAB-VFRM)